Biobehavioral mechanisms of topiramate's effects on alcohol use: an investigation pairing laboratory and ecological momentary assessments

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Addiction Biology

• Publication date

  2016-01-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1111/adb.12192PMID 25353306PMCID PMC4414660
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Applied Longitudinal Data Analysis Modeling Change And Event Occurrence

  2016cited by this paper
• Characterizing subjective responses to alcohol among adolescent problem drinkers.

  2014influential reference
• GRIK1 genotype moderates topiramate's effects on daily drinking level, expectations of alcohol's positive effects and desire to drink.

  2014cited by this paper
• Topiramate Treatment of Heavy Drinkers: Moderation by a GRIK1 Polymorphism

  2014influential reference
• Effects of naltrexone on adolescent alcohol cue reactivity and sensitivity: an initial randomized trial

  2014influential reference
• Topiramate treatment for heavy drinkers: moderation by a GRIK1 polymorphism.

  2014cited by this paper
• Novel Metabolic Drugs and Blood Pressure: Implications for the Treatment of Obese Hypertensive Patients?

  2013cited by this paper
• Topiramate treatment for alcoholic outpatients recently receiving residential treatment programs: a 12-week, randomized, placebo-controlled trial.

  2013cited by this paper
• Alcohol craving in adolescents: bridging the laboratory and natural environment

  2013cited by this paper
• Binge drinking - United States, 2011.

  2013cited by this paper
• Responses to alcohol and cigarette use during ecologically assessed drinking episodes

  2012cited by this paper
• Treatment of alcohol dependence with low-dose topiramate: an open-label controlled study

  2011cited by this paper
• Advances in analysis of longitudinal data.

  2010cited by this paper
• Bayesian Analysis In Mplus : A Brief Introduction

  2010cited by this paper
• A general multilevel SEM framework for assessing multilevel mediation.

  2010cited by this paper
• Polymorphisms of the mu-opioid receptor and dopamine D4 receptor genes and subjective responses to alcohol in the natural environment.

  2010influential reference
• Expanding the utility of the Biphasic Alcohol Effects Scale (BAES) and initial psychometric support for the Brief-BAES (B-BAES).

  2009cited by this paper
• Modulation of Impulsivity by Topiramate: Implications for the Treatment of Alcohol Dependence

  2009cited by this paper
• REVIEW: HPA‐axis activity in alcoholism: examples for a gene–environment interaction

  2008cited by this paper
• Comparing topiramate with naltrexone in the treatment of alcohol dependence.

  2008influential reference
• Effects of topiramate on urge to drink and the subjective effects of alcohol: a preliminary laboratory study.

  2008influential reference
• Moderators of naltrexone's effects on drinking, urge, and alcohol effects in non-treatment-seeking heavy drinkers in the natural environment.

  2007influential reference
• Topiramate for treating alcohol dependence: a randomized controlled trial.

  2007influential reference
• Pharmacological treatment of alcohol dependence: target symptoms and target mechanisms.

  2006cited by this paper
• Computational Tools for Probing Interactions in Multiple Linear Regression, Multilevel Modeling, and Latent Curve Analysis

  2006cited by this paper
• The COMBINE SAFTEE: a structured instrument for collecting adverse events adapted for clinical studies in the alcoholism field.

  2005cited by this paper
• Using calculations to estimate blood alcohol concentrations for naturally occurring drinking episodes: a validity study.

  2005cited by this paper
• A meta-analysis of alcohol consumption and the risk of 15 diseases.

  2004cited by this paper
• Effects of topiramate in the treatment of alcohol dependence.

  2004cited by this paper
• Oral topiramate for treatment of alcohol dependence: a randomised controlled trial.

  2003influential reference
• Fatal nontraffic injuries involving alcohol: A metaanalysis.

  1999cited by this paper
• Levels and patterns of alcohol consumption using timeline follow-back, daily diaries and real-time "electronic interviews".

  1998cited by this paper
• Behavioral effects and pharmacokinetics of low-dose intravenous alcohol in humans.

  1997cited by this paper
• Assessment of medication compliance in alcoholics through UV light detection of a riboflavin tracer.

  1996cited by this paper
• Development and validation of the Biphasic Alcohol Effects Scale.

  1993cited by this paper
• Timeline Follow-Back A Technique for Assessing Self-Reported Alcohol Consumption

  1992cited by this paper
• Assessment of alcohol withdrawal: the revised clinical institute withdrawal assessment for alcohol scale (CIWA-Ar).

  1989cited by this paper
• Reactivity of alcoholics and nonalcoholics to drinking cues.

  1987cited by this paper
• SAFTEE: a technique for the systematic assessment of side effects in clinical trials.

  1986cited by this paper
• Estimating blood alcohol concentration: two computer programs and their applications in therapy and research.

  1979influential reference
• Society for the Study of Addiction

  1977cited by this paper

• Preliminary effects of oral ANS-6637, an ALDH2 inhibitor, on cue-induced craving, safety and alcohol consumption among adults with alcohol use disorder: a proof-of-concept, randomized, human laboratory trial.

  2025cites this paper
• Medications for Alcohol Use Disorder: a Harm Reduction Perspective

  2025cites this paper
• Real-Time Exposure to Intersectional Minority Stressors and Alcohol Use: Protocol for an Ecological Momentary Assessment Study With Latinx and Non-Latinx Sexual Minority Youth

  2025cites this paper
• High‐ and low‐dose topiramate for the treatment of persons with alcohol use disorder who smoke cigarettes: A randomized control trial

  2025cites this paper
• Planned versus Unplanned Daily Substance Use among Sexual Minority Youth: The Moderating Role of Social Norms.

  2025cites this paper
• Dynamic associations between cannabis use and sleep in adolescents and young adults during a cannabis intervention trial.

  2025cites this paper
• The neural and psychophysiological effects of cannabidiol in youth with alcohol use disorder: A randomized controlled clinical trial

  2025cites this paper
• Endpoints for Pharmacotherapy Trials for Alcohol Use Disorder

  2024cites this paper
• The use of Experience Sampling Method in psychopharmacological studies: A systematic review.

  2024cites this paper
• Examining Caregiver Practices During Adolescent Outpatient Alcohol Use and Co-Occurring Mental Health Treatment: Protocol for a Dyadic Ecological Momentary Assessment Study

  2024cites this paper
• From alcohol and other drug treatment mediator to mechanism to implementation: A systematic review and the cases of self-efficacy, social support, and craving.

  2024cites this paper
• Design and rationale for a randomized clinical trial testing the efficacy of a lifestyle physical activity intervention for people with HIV and engaged in unhealthy drinking.

  2024cites this paper
• Advancements in addressing drug dependence: A review of promising therapeutic strategies and interventions.

  2024cites this paper
• Does sleep relate to next-day cannabis use during treatment? Findings from an adolescent and young adult motivational enhancement and cognitive behavioral therapy plus topiramate intervention.

  2023cites this paper
• Beyond mediators: A critical review and methodological path forward for studying mechanisms in alcohol use treatment research.

  2023cites this paper
• Testing pharmacotherapies for alcohol use disorder with cue exposure paradigms: A systematic review and quantitative synthesis of human laboratory trial methodology.

  2023cites this paper
• Topiramate decreases the salience of motivationally relevant visual cues among smokers with alcohol use disorder.

  2022cites this paper
• Behavioral economic analysis of topiramate pharmacotherapy for alcohol: a placebo-controlled investigation of effects on alcohol reinforcing value and delayed reward discounting

  2022cites this paper
• The neurobiological markers of acute alcohol’s subjective effects in humans

  2022cites this paper
• Alcohol use disorder in community management of chronic liver diseases

  2022cites this paper
• The effect of neuroimmune modulation on subjective response to alcohol in the natural environment.

  2022cites this paper
• Informatization of the procedure of medical examination for alcohol or drug intoxication in the Republic of Kazakhstan

  2022cites this paper
• Behavioral economic analysis of topiramate pharmacotherapy for alcohol: a placebo-controlled investigation of effects on alcohol reinforcing value and delayed reward discounting

  2022cites this paper
• Alcohol Subjective Responses in Heavy Drinkers: Measuring Acute Effects in the Natural Environment Versus the Controlled Laboratory Setting.

  2021cites this paper
• The Anticonvulsant Lamotrigine Reduces Bout-Like Alcohol Drinking in Rats.

  2021cites this paper
• Daily associations between alcohol and sweets craving and consumption in early AUD recovery: Results from an ecological momentary assessment study.

  2021cites this paper
• Substance Use and Addiction Affect More Than the Brain: the Promise of Neurocardiac Interventions

  2021cites this paper
• Combined pharmacotherapy and evidence-based psychosocial Cannabis treatment for youth and selection of cannabis-using friends.

  2021cites this paper
• Effects of topiramate on neural responses to alcohol cues in treatment-seeking individuals with alcohol use disorder: preliminary findings from a randomized, placebo-controlled trial

  2021cites this paper
• Why don't they stop? Understanding unplanned marijuana use among adolescents and young adults.

  2020cites this paper
• Translational approach to understanding momentary factors associated with alcohol consumption

  2020cites this paper
• Co-use of medication and alcohol: The influence on subjective effects of intoxication and affect.

  2020cites this paper
• Topiramate Pharmacotherapy for Alcohol Use Disorder and Other Addictions: A Narrative Review

  2019cites this paper
• Assessment of Alcohol Use in the Natural Environment

  2019cites this paper
• Medication Development for Alcohol Use Disorder: A Focus on Clinical Studies.

  2019cites this paper
• The Human Laboratory and Drug Development in Alcohol Use Disorder: Recent Updates.

  2019cites this paper
• Rate of alcohol consumption in the daily life of adolescents and emerging adults

  2019cites this paper
• Using REDCap for ambulatory assessment: Implementation in a clinical trial for smoking cessation to augment in-person data collection

  2019cites this paper
• Mobile alcohol biosensors and pharmacotherapy development research.

  2019cites this paper
• Novel Psychoactive Drugs

  2019cites this paper
• Why cognitive event-related potentials (ERPs) should have a role in the management of alcohol disorders.

  2019cites this paper
• Cardiac vagal dysfunction moderates patterns of craving across the day in moderate to heavy consumers of alcohol

  2018cites this paper
• e-Addictology: An Overview of New Technologies for Assessing and Intervening in Addictive Behaviors

  2018cites this paper
• Real-time assessment of alcohol craving and naltrexone treatment responsiveness in a randomized clinical trial.

  2018cites this paper
• Advances in Pharmacotherapy Development: Human Clinical Studies.

  2018cites this paper
• Using ecological momentary assessment to examine the relationship between craving and affect with opioid use in a clinical trial of clonidine as an adjunct medication to buprenorphine treatment

  2018cites this paper
• Using Ecological Momentary Assessment to Identify Mechanisms of Change: An Application From a Pharmacotherapy Trial With Adolescent Cannabis Users.

  2018influential citation
• Advancing Analytic Approaches to Address Key Questions in Mechanisms of Behavior Change Research.

  2018cites this paper
• Comparing and Combining Topiramate and Aripiprazole on Alcohol-Related Outcomes in a Human Laboratory Study

  2018cites this paper
• Multilevel Mediation With Small Samples: A Cautionary Note on the Multilevel Structural Equation Modeling Framework

  2017cites this paper
• The Corticotropin Releasing Factor Receptor 1 in Alcohol Use Disorder: Still a Valid Drug Target?

  2017cites this paper
• Alcohol-seeking and relapse: A focus on incentive salience and contextual conditioning.

  2017cites this paper
• Elevated Behavioral Economic Demand for Alcohol in a Community Sample of Heavy Drinking Smokers.

  2017cites this paper
• Topiramate and motivational enhancement therapy for cannabis use among youth: a randomized placebo‐controlled pilot study

  2017cites this paper
• Alcohol Stimulation and Sedation: a Critical Review of the Biphasic Alcohol Effects Scale

  2017cites this paper
• Potential Medications for the Treatment of Alcohol Use Disorder: An Evaluation of Clinical Efficacy and Safety

  2016cites this paper
• Mechanisms of topiramate effects: refining medications development for alcoholism

  2016cites this paper
• Acute subjective response to alcohol as a function of reward and punishment sensitivity.

  2016cites this paper
• Emerging Pharmacologic Treatments for Adolescent Substance Use: Challenges and New Directions

  2016cites this paper
• Mechanisms of topiramate effects: refining medications development for alcoholism

  2016cites this paper
• Mechanisms of topiramate effects: how and for whom does it work?

  2015cites this paper
• Recommendations for the Design and Analysis of Treatment Trials for Alcohol Use Disorders.

  2015cites this paper
• Pharmacological Treatment Options for Alcohol Use Disorder

  2015cites this paper
• Active Ingredients of Treatment and Client Mechanisms of Change in Behavioral Treatments for Alcohol Use Disorders: Progress 10 Years Later.

  2015cites this paper
• *Abridged version of the "Therapeutic Guideline for Alcohol Use Disorder" prepared by the Working Group Therapeutic Guideline for Alcohol Use Disorder.

  2015cites this paper